Literature DB >> 3010942

Interaction between calmodulin and five different spin-labelled chlorophenothiazines.

J L Olivier, D Rainteau, G Bereziat, C Wolf.   

Abstract

The binding to purified calmodulin of five spin-labelled derivatives of chlorophenothiazine was investigated by e.s.r. spectrometry and by the antagonizing potency on the calmodulin-dependent activation of myosin light chain kinase. The results of a comparative study and the influence of pH and ionic strength on the binding support the occurrence of an electrostatic binding involving the terminal amino group of the side-chain of the chlorophenothiazine. These results are discussed in relation to the specificity of the interaction that holds the antipsychotic drug-calmodulin complex together.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3010942      PMCID: PMC1153107          DOI: 10.1042/bj2330853

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  13 in total

1.  Calcium and cyclic nucleotide dependent regulatory mechanisms during development of chick embryo skeletal muscle.

Authors:  C J Le Peuch; C Ferraz; M P Walsh; J G Demaille; E H Fischer
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

2.  Mechanism by which psychotropic drugs inhibit adenosine cyclic 3',5'-monophosphate phosphodiesterase of brain.

Authors:  R M Levin; B Weiss
Journal:  Mol Pharmacol       Date:  1976-07       Impact factor: 4.436

3.  Association of calmodulin inhibition, erythrocyte membrane stabilization and pharmacological effects of drugs.

Authors:  U L Bereza; G J Brewer; I Mizukami
Journal:  Biochim Biophys Acta       Date:  1982-11-08

4.  Phenothiazine antagonism of calmodulin: a structurally-nonspecific interaction.

Authors:  B D Roufogalis
Journal:  Biochem Biophys Res Commun       Date:  1981-02-12       Impact factor: 3.575

5.  The interaction of calmodulin with amphiphilic peptides.

Authors:  J A Cox; M Comte; J E Fitton; W F DeGrado
Journal:  J Biol Chem       Date:  1985-02-25       Impact factor: 5.157

6.  Differences in the association of calmodulin with cyclic nucleotide phosphodiesterase in relaxed and contracted arterial strips.

Authors:  Y Saitoh; J G Hardman; J N Wells
Journal:  Biochemistry       Date:  1985-03-26       Impact factor: 3.162

7.  Functional properties of covalent beta-endorphin peptide/calmodulin complexes. Chlorpromazine binding and phosphodiesterase activation.

Authors:  D P Giedroc; T M Keravis; J V Staros; N Ling; J N Wells; D Puett
Journal:  Biochemistry       Date:  1985-02-26       Impact factor: 3.162

8.  Chlorpromazine, methotrimeprazine, and metabolites. Structural changes accompanying the loss of neuroleptic potency by ring sulfoxidation.

Authors:  S G Dahl; M Hjorth; E Hough
Journal:  Mol Pharmacol       Date:  1982-03       Impact factor: 4.436

9.  Interaction of quaternary phenothiazine salts with calmodulin.

Authors:  W C Prozialeck
Journal:  J Pharmacol Exp Ther       Date:  1984-12       Impact factor: 4.030

10.  Hydrophobic interaction of the Ca2+-calmodulin complex with calmodulin antagonists. Naphthalenesulfonamide derivatives.

Authors:  T Tanaka; T Ohmura; H Hidaka
Journal:  Mol Pharmacol       Date:  1982-09       Impact factor: 4.436

View more
  1 in total

1.  Binding of two spin-labelled derivatives of chlorpromazine to human erythrocytes.

Authors:  J L Olivier; C Chachaty; C Wolf; D Daveloose; G Bereziat
Journal:  Biochem J       Date:  1989-12-15       Impact factor: 3.857

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.